Companion Diagnostic Development

For any biomarkers that demonstrate promise as a companion or complementary diagnostic, Precision Oncology provides services to enable the complete development and global registration of these diagnostics.  To date, our team has completed:

• 100+ IVD and device pre-submissions, preclinical/clinical trial designs and executions

• 250+ Proven marketing clearances and approvals for device and IVD submissions

• 100 Country global companion diagnostic filings for 3 companion diagnostic partnerships

Related Article: Precision for Medicine Acquires Applied Immunology